BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1855318)

  • 21. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
    Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V
    Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of atrial natriuretic hormone on vasopressin and thirst response to osmotic stimulation in human subjects.
    Wazna-Wesly JM; Meranda DL; Carey P; Shenker Y
    J Lab Clin Med; 1995 Jun; 125(6):734-42. PubMed ID: 7769367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome.
    Watanabe H; Lau DC; Guyn HL; Wong NL
    Clin Invest Med; 1997 Aug; 20(4):211-23. PubMed ID: 9258576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of changes in plasma hepatic-portal and systemic osmolality on plasma concentrations of arginine vasopressin in conscious newborn calves.
    Kati-Coulibaly S; Giry J; Barlet JP
    J Dev Physiol; 1989 Oct; 12(4):183-7. PubMed ID: 2634058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osmotic control of plasma vasopressin in anesthetized dogs.
    Bie P; Peterson TV; Share L; Gilmore JP
    Acta Physiol Scand; 1982 Jan; 114(1):37-43. PubMed ID: 7136744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked improvement in bone metabolism parameters after increasing the dialysate calcium concentration from 2.5 to 3 mEq/L in nonhypercalcemic hemodialysis patients.
    Molina Vila P; Sánchez Pérez P; Garrigós Almerich E; Peris Domingo A
    Hemodial Int; 2008 Jan; 12(1):73-9. PubMed ID: 18271845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thirst perception, plasma osmolality and estimated plasma arginine vasopressin concentration in dehydrated and oral saline loaded subjects.
    Obika LO; Amabebe E; Ozoene JO; Inneh CA
    Niger J Physiol Sci; 2013 Jun; 28(1):83-9. PubMed ID: 23955413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of changes in ionized calcium on cardiovascular reactivity during hemodialysis.
    van Kuijk WH; Mulder AW; Peels CH; Harff GA; Leunissen KM
    Clin Nephrol; 1997 Mar; 47(3):190-6. PubMed ID: 9105767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
    Teruel JL; Nitvarro JF; Marcen R; Aguilera A; Tato A; Ottuño J
    Miner Electrolyte Metab; 1997; 23(1):19-24. PubMed ID: 9058365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical control study of dialysates with different concentrations of calcium on blood pressure in patients under hemodialysis for prolonged period].
    Wang C; Lou TQ; Chen ZJ; Tang H; Shi CG; Yu XQ; Yin PD
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):236-8. PubMed ID: 17448281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment.
    Marcisz C; Jonderko G; Kucharz EJ
    Med Sci Monit; 2001; 7(3):409-14. PubMed ID: 11386017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apelin, plasmatic osmolality and hypotension in dialyzed patients.
    Cernaro V; Lacquaniti A; Lorenzano G; Loddo S; Romeo A; Donato V; Lupica R; Buemi A; Buemi M
    Blood Purif; 2012; 33(4):317-23. PubMed ID: 22699819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of Plasma Arginine Vasopressin Concentration Using Thirst Perception and Plasma Osmolality Values.
    Obika LF; Ozoene JO
    Niger J Physiol Sci; 2014 Dec; 29(2):119-24. PubMed ID: 26196577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible vasopressin deficiency in severe hypernatremia.
    Cooke CR; Wall BM; Jones GV; Presley DN; Share L
    Am J Kidney Dis; 1993 Jul; 22(1):44-52. PubMed ID: 8322792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central venous pressure and plasma arginine vasopressin in man during water immersion combined with changes in blood volume.
    Norsk P; Bonde-Petersen F; Warberg J
    Eur J Appl Physiol Occup Physiol; 1986; 54(6):608-16. PubMed ID: 3948857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?
    Ettema EM; Kuipers J; Assa S; Bakker SJ; Groen H; Westerhuis R; Gaillard CA; Gansevoort RT; Franssen CF
    PLoS One; 2015; 10(5):e0127116. PubMed ID: 25973954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis.
    Ettema EM; Kuipers J; Groen H; Kema IP; Westerhuis R; de Jong PE; Franssen CF
    Nephrol Dial Transplant; 2012 Aug; 27(8):3263-70. PubMed ID: 22323529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of hydration state on hormonal responses to exercise in dogs.
    Baker MA; Doris PA; Turlejska E
    J Physiol Pharmacol; 1991 Sep; 42(3):305-16. PubMed ID: 1793891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous and exogenous vasopressin during hemodialysis.
    Thompson AM; Oliver JA
    Semin Dial; 2009; 22(5):472-5. PubMed ID: 19522759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.